What are the most appropriate operation procedures for endometrial cancer?

Daisuke Aoki, Y. Udagawa, S. Nozawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In the treatment of endometrial cancer, surgical treatment, radiotherapy, chemotherapy, and hormonal therapy are available. Since endometrial cancers are adenocarcinoma with a relatively low response to irradiation in most a cases, surgical operation is the first choice in these cases. The operative procedure is chosen according to the cancer staging currently used in Japan (FIGO, 1982), because it is a preoperative staging. In principle, total hysterectomy is done for cases of stage 0, modified radical hysterectomy for stage I, radical hysterectomy for stage II, and radical hysterectomy combined with resection of the metastatic lesions for stage III and IV. In addition, adnexa has to be resected bilaterally. In cases of stage II or higher stages, resection of pars aortic lymph nodes is done in addition to pelvic lymphadenectomy according to the depth of myometrial invasion and histologic type. On the other hand, the new international corpus cancer staging employed by FIGO in 1988 is a surgical staging which determines the stage on the basis of the intraoperative and postoperative histopathological findings. This staging takes into account more prognostic factors, reflecting the prognosis more precisely. In the near future, the Japan Society of Obstetrics and Gynecology will introduce a new staging. Since this staging is, however, determined postoperatively, it cannot be a criterion for choosing operative procedures. In addition, it is well known that preoperative diagnosis is not always consistent with intraabdominal findings. Therefore, it is important to determine most appropriate operative procedure by checking preoperatively the prognostic factors such as histopathology, degree of differentiation, cervical involvement, myometrial invasion and presence or absence of extrauterine progression precisely as far as possible. At the same time, by taking into consideration the intraoperative findings, an extended operation not limited to the above mentioned procedures should be undertaken in cases with higher risk factors.

Original languageEnglish
Pages (from-to)1163-1168
Number of pages6
JournalJapanese Journal of Cancer and Chemotherapy
Volume22
Issue number9
Publication statusPublished - 1995

Fingerprint

Endometrial Neoplasms
Hysterectomy
Operative Surgical Procedures
Neoplasm Staging
Japan
Lymph Node Excision
Gynecology
Obstetrics
Adenocarcinoma
Radiotherapy
Therapeutics
Lymph Nodes
Drug Therapy

Keywords

  • Endometrial cancer
  • Surgical operation
  • Surgical staging

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

What are the most appropriate operation procedures for endometrial cancer? / Aoki, Daisuke; Udagawa, Y.; Nozawa, S.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 22, No. 9, 1995, p. 1163-1168.

Research output: Contribution to journalArticle

@article{f625266c0a544fc7b29abda8c4002c1e,
title = "What are the most appropriate operation procedures for endometrial cancer?",
abstract = "In the treatment of endometrial cancer, surgical treatment, radiotherapy, chemotherapy, and hormonal therapy are available. Since endometrial cancers are adenocarcinoma with a relatively low response to irradiation in most a cases, surgical operation is the first choice in these cases. The operative procedure is chosen according to the cancer staging currently used in Japan (FIGO, 1982), because it is a preoperative staging. In principle, total hysterectomy is done for cases of stage 0, modified radical hysterectomy for stage I, radical hysterectomy for stage II, and radical hysterectomy combined with resection of the metastatic lesions for stage III and IV. In addition, adnexa has to be resected bilaterally. In cases of stage II or higher stages, resection of pars aortic lymph nodes is done in addition to pelvic lymphadenectomy according to the depth of myometrial invasion and histologic type. On the other hand, the new international corpus cancer staging employed by FIGO in 1988 is a surgical staging which determines the stage on the basis of the intraoperative and postoperative histopathological findings. This staging takes into account more prognostic factors, reflecting the prognosis more precisely. In the near future, the Japan Society of Obstetrics and Gynecology will introduce a new staging. Since this staging is, however, determined postoperatively, it cannot be a criterion for choosing operative procedures. In addition, it is well known that preoperative diagnosis is not always consistent with intraabdominal findings. Therefore, it is important to determine most appropriate operative procedure by checking preoperatively the prognostic factors such as histopathology, degree of differentiation, cervical involvement, myometrial invasion and presence or absence of extrauterine progression precisely as far as possible. At the same time, by taking into consideration the intraoperative findings, an extended operation not limited to the above mentioned procedures should be undertaken in cases with higher risk factors.",
keywords = "Endometrial cancer, Surgical operation, Surgical staging",
author = "Daisuke Aoki and Y. Udagawa and S. Nozawa",
year = "1995",
language = "English",
volume = "22",
pages = "1163--1168",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "9",

}

TY - JOUR

T1 - What are the most appropriate operation procedures for endometrial cancer?

AU - Aoki, Daisuke

AU - Udagawa, Y.

AU - Nozawa, S.

PY - 1995

Y1 - 1995

N2 - In the treatment of endometrial cancer, surgical treatment, radiotherapy, chemotherapy, and hormonal therapy are available. Since endometrial cancers are adenocarcinoma with a relatively low response to irradiation in most a cases, surgical operation is the first choice in these cases. The operative procedure is chosen according to the cancer staging currently used in Japan (FIGO, 1982), because it is a preoperative staging. In principle, total hysterectomy is done for cases of stage 0, modified radical hysterectomy for stage I, radical hysterectomy for stage II, and radical hysterectomy combined with resection of the metastatic lesions for stage III and IV. In addition, adnexa has to be resected bilaterally. In cases of stage II or higher stages, resection of pars aortic lymph nodes is done in addition to pelvic lymphadenectomy according to the depth of myometrial invasion and histologic type. On the other hand, the new international corpus cancer staging employed by FIGO in 1988 is a surgical staging which determines the stage on the basis of the intraoperative and postoperative histopathological findings. This staging takes into account more prognostic factors, reflecting the prognosis more precisely. In the near future, the Japan Society of Obstetrics and Gynecology will introduce a new staging. Since this staging is, however, determined postoperatively, it cannot be a criterion for choosing operative procedures. In addition, it is well known that preoperative diagnosis is not always consistent with intraabdominal findings. Therefore, it is important to determine most appropriate operative procedure by checking preoperatively the prognostic factors such as histopathology, degree of differentiation, cervical involvement, myometrial invasion and presence or absence of extrauterine progression precisely as far as possible. At the same time, by taking into consideration the intraoperative findings, an extended operation not limited to the above mentioned procedures should be undertaken in cases with higher risk factors.

AB - In the treatment of endometrial cancer, surgical treatment, radiotherapy, chemotherapy, and hormonal therapy are available. Since endometrial cancers are adenocarcinoma with a relatively low response to irradiation in most a cases, surgical operation is the first choice in these cases. The operative procedure is chosen according to the cancer staging currently used in Japan (FIGO, 1982), because it is a preoperative staging. In principle, total hysterectomy is done for cases of stage 0, modified radical hysterectomy for stage I, radical hysterectomy for stage II, and radical hysterectomy combined with resection of the metastatic lesions for stage III and IV. In addition, adnexa has to be resected bilaterally. In cases of stage II or higher stages, resection of pars aortic lymph nodes is done in addition to pelvic lymphadenectomy according to the depth of myometrial invasion and histologic type. On the other hand, the new international corpus cancer staging employed by FIGO in 1988 is a surgical staging which determines the stage on the basis of the intraoperative and postoperative histopathological findings. This staging takes into account more prognostic factors, reflecting the prognosis more precisely. In the near future, the Japan Society of Obstetrics and Gynecology will introduce a new staging. Since this staging is, however, determined postoperatively, it cannot be a criterion for choosing operative procedures. In addition, it is well known that preoperative diagnosis is not always consistent with intraabdominal findings. Therefore, it is important to determine most appropriate operative procedure by checking preoperatively the prognostic factors such as histopathology, degree of differentiation, cervical involvement, myometrial invasion and presence or absence of extrauterine progression precisely as far as possible. At the same time, by taking into consideration the intraoperative findings, an extended operation not limited to the above mentioned procedures should be undertaken in cases with higher risk factors.

KW - Endometrial cancer

KW - Surgical operation

KW - Surgical staging

UR - http://www.scopus.com/inward/record.url?scp=0029090397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029090397&partnerID=8YFLogxK

M3 - Article

C2 - 7661567

AN - SCOPUS:0029090397

VL - 22

SP - 1163

EP - 1168

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 9

ER -